Acura Pharmaceuticals reported 613K in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.86M 1.42M
Acura Pharmaceuticals ACUR:US 613K 31K
Intra Cellular Therapies ITCI:US $ 22.21M 2.16M
Johnson & Johnson JNJ:US $ 23338M 26M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pfizer PFE:US $ 24094M 5117M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Shionogi 4507:JP Y 76120M 7155M
Sun Pharmaceuticals SUNP:IN IR 96259.3M 928.1M
Teva Pharmaceutical TEVA:IT 3.89B 23M
Xeris Pharmaceuticals Inc XERS:US $ 11.06M 2.15M
Zogenix ZGNX:US $ 22.61M 3.82M